VanEck Biotech ETF (BBH)
159.87
2.05 (1.30%)
At close: Jan 15, 2025, 2:33 PM
undefined% (undefined)
| Bid | 159.85 |
| Market Cap | 393.90M |
| AUM | - |
| NAV | - |
| EPS (ttm) | 5.12 |
| PE Ratio (ttm) | 31.22 |
| Shares Out | 2.46M |
| Inception Date | Invalid Date |
| Ask | 160.05 |
| Volume | 10.36K |
| Open | 159.57 |
| Previous Close | 157.82 |
| Day's Range | 159.23 - 160.38 |
| 52-Week Range | 151.35 - 183.64 |
| Holdings | - |
| Expense Ratio | undefined% |
About BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol BBH
Inception Date Nov 23, 1999
Provider Vaneck
Website Fund Home Page
Top Holdings 49.45% of assets
| Company | Portfolio |
|---|---|
Amgen Inc | 15.69% |
Gilead Sciences Inc | 11.15% |
Vertex Pharmaceutica... | 10.44% |
Regeneron Pharmaceut... | 6.50% |
Argenx Se | 5.67% |
Dividends Dividend Yield 0.79%
| Ex-Dividend | Payment Date | Amount |
|---|---|---|
| Dec 23, 2024 | Dec 24, 2024 | $1.25 |
| Dec 18, 2023 | Dec 22, 2023 | $0.71 |
| Dec 19, 2022 | Dec 23, 2022 | $0.75 |
| Dec 20, 2021 | Dec 27, 2021 | $0.40 |
| Dec 21, 2020 | Dec 28, 2020 | $0.61 |
